Reckitt Benckiser: Dettol, Durex and Gaviscon drive growth but America lags Retail Consumer goods giant Reckitt Benckiser has reported an uptick in profit driven by its core brands and emerging markets despite a slowdown in North America. Group revenue at the company rose by 1.1 per cent in the first quarter of the year. This growth was driven by emerging markets China and India, where like-for-like revenue [...]
Dettol and Nurofen owner Reckitt to sell divisions as it slims down Retail Dettol, Lysol, Durex, and Nurofen owner Reckitt has delivered a mixed financial performance for 2024, with modest like-for-like revenue growth and increased profitability but a decline in reported net revenue due to foreign exchange impacts. Like-for-like net revenue rose 1.4 per cent, driven by gains in Hygiene and Health, while Nutrition declined. Hygiene and Health [...]
Reckitt: FTSE 100 giant’s revenue slides amid restructuring Retail Reckitt has reported a drop in like-for-like revenue as the company continues to struggle after the pandemic. For the third quarter the company reported like-for-like net revenue growth of -0.5 per cent, although revenue increased 0.4 per cent for the year to 30 September. Overall, the group reported a net revenue decline of four per [...]
Market shrugs at Durex owner Reckitt’s growth and simplification plan July 24, 2024 Durex condom maker Reckitt Benckiser has pledged to sell off its home care and nutrition brands as part of a simplification drive, instead focusing on health and hygiene.
Reckitt Benckiser: ‘Significant damage’ from tornado will hit baby formula sales July 17, 2024 Baby formula sales at Reckitt Benckiser are set to be hit by “significant damage” to a warehouse which was struck by a tornado, the consumer hygiene company has said.
Reckitt Benckiser: Nutrition arm bruised amid baby formula litigation case April 24, 2024 Like-for-like sales at its nutrition arm fell by 9.9 per cent to £591m, which more than offset growth of 7.1 per cent at its hygiene arm and one per cent at its health arm.
Shares in Durex maker Reckitt flop as firm misses expectations February 28, 2024 Shares in Durex condom maker Reckitt Benckiser have flopped over nine per cent after the firm missed analyst expectations and revenues showed signs of slowing.
Indivior plans primary US listing in another hit to London’s flagging equity market February 22, 2024 While the firm said it would look to maintain a secondary listing in the UK, the decision to shift its primary listing marks a big change for the company.